The translational science of Marfan syndrome

Jondeau, Guillaume; Michel, Jean Baptiste; Boileau, Catherine
August 2011
Heart;Aug2011, Vol. 97 Issue 15, p1206
Academic Journal
Marfan syndrome has changed over the last few years: new diagnostic criteria have been proposed, new clinical entities recognised and life expectancy increased. The role of fibrillin 1, which was initially thought to be mainly structural, has been shown to also be functional. The altered transforming growth factor b pathway is better understood, the importance of epigenetic factors has been demonstrated and recent data suggest that many of the observations made in Marfan syndrome can actually be made in thoracic aortic aneurysm from diverse aetiologies. Besides transforming growth factor β, the role of metalloproteinase, the fibrinolytic/coagulation system, is being suggested in the progression of the disease. A relationship between the type of fibrillin 1 (FBN1) gene mutation and the mechanism for the disease (haploinsufficiency vs negative dominance), as well as some genotype/phenotype correlations, has been observed, although the main challenge of recognising gene modifiers has yet to explain tremendous variability despite similar mutation. This progress has led to new hopes for tomorrow's therapies, some of which are being tested in clinics, whereas others are still in the field of animal models. Here we review some of the new data obtained in the understanding of the pathophysiology and genetics of this disease.


Related Articles

  • Mutations of the TGFBR2 gene in Chinese patients with Marfan-related syndrome. Chen JinLan; Li BuYun; Yang YiFeng; Hu JianGuo; Zhao TianLi; Gong YiBo; Tan ZhiPing // Clinical & Investigative Medicine;Feb2010, Vol. 33 Issue 1, pE14 

    Purpose: Transforming growth factor beta receptors II gene (TGFBR2) mutations associated with Marfan syndrome and Marfan-associated disorders have been investigated. However, such studies are limited in China. To obtain more information about TGFBR2 mutations, we analyzed 6 unrelated Chinese...

  • Arterial tortuosity and aneurysm in a case of Loeys-Dietz syndrome type IB with a mutation p.RS37P in the TGFBR2 gene. Kılıc, Esra; Alanay, Yasemin; Ütine, Eda; Özgen-Mocan, Burçe; Robinson, Peter N.; Boduroğlu, Koray // Turkish Journal of Pediatrics;Mar/Apr2012, Vol. 54 Issue 2, p198 

    We report a 13-year-old girl with Loeys-Dietz syndrome (LDS) caused by a known transforming growth factor beta receptor II (TGFBR2) gene mutation, who developed aortic root dilatation and saccular aneurysm of the internal carotid artery. LDS is a rare, autosomal dominant aortic aneurysm syndrome...

  • Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Lindsay, Mark E; Schepers, Dorien; Bolar, Nikhita Ajit; Doyle, Jefferson J; Gallo, Elena; Fert-Bober, Justyna; Kempers, Marlies J E; Fishman, Elliot K; Chen, Yichun; Myers, Loretha; Bjeda, Djahita; Oswald, Gretchen; Elias, Abdallah F; Levy, Howard P; Anderlid, Britt-Marie; Yang, Margaret H; Bongers, Ernie M H F; Timmermans, Janneke; Braverman, Alan C; Canham, Natalie // Nature Genetics;Aug2012, Vol. 44 Issue 8, p922 

    Loeys-Dietz syndrome (LDS) associates with a tissue signature for high transforming growth factor (TGF)-? signaling but is often caused by heterozygous mutations in genes encoding positive effectors of TGF-? signaling, including either subunit of the TGF-? receptor or SMAD3, thereby engendering...

  • Dysregulation of TGF-B activation contributes to pathogenesis in Marfan syndrome. Neptune, Enid R.; Frischmeyer, Pamela A.; Arking, Dan E.; Myers, Loretha; Bunton, Tracie E.; Gayraud, Barbara; Ramirez, Francesco; Sakai, Lynn Y.; Dietz, Harry C. // Nature Genetics;Mar2003, Vol. 33 Issue 3, p407 

    Marfan syndrome is an autosomal dominant disorder of connective tissue caused by mutations in fibrillin-1 (encoded by FBN1 in humans and Fbn1 in mice), a matrix component of extracellular microfibrils. A distinct subgroup of individuals with Marfan syndrome have distal airspace enlargement,...

  • Mutations in the gene encoding the latency-associated peptide of TGF-β1 cause Camurati-Engelmann disease. Janssens, Katrien; Gershoni-Baruch, Ruth; Guañabens, Nuria; Migone, Nicola; Ralston, Stuart; Bonduelle, Maryse; Lissens, Willy; Van Maldergem, Lionel; Vanhoenacker, Filip; Verbruggen, Leon; Van Hul, Wim // Nature Genetics;Nov2000, Vol. 26 Issue 3, p273 

    Camurati-Engelmann disease (CED; MIM 131300), or progressive diaphyseal dysplasia, is a rare, sclerosing bone dysplasia inherited in an autosomal dominant manner. Recently, the gene causing CED has been assigned to the chromosomal region 19q13 (refs 1?3). Because this region contains the gene...

  • Absence of TGFBR2 mutations in patients with spontaneous spinal CSF leaks and intracranial hypotension. Schievink, Wouter I.; Gordon, Ora K.; Hyland, James C.; Ala-Kokko, Leena // Journal of Headache & Pain;Apr2008, Vol. 9 Issue 2, p99 

    A heritable connective-tissue-disorder often is suspected in patients with spontaneous spinal CSF leaks and intracranial hypotension, but the nature of the disorder remains unknown in most patients. The aim of this study was to assess the gene encoding TGF-β receptor-2 ( TGFBR2) as a...

  • Biventricular and atrial diastolic function assessment using conventional echocardiography and tissue-Doppler imaging in adults with Marfan syndrome†. Kiotsekoglou, Anatoli; Moggridge, James C.; Bijnens, Bart H.; Kapetanakis, Venediktos; Alpendurada, Francisco; Mullen, Michael J.; Saha, Samir; Nassiri, Dariush K.; Camm, John; Sutherland, George R.; Child, Anne H. // European Journal of Echocardiography;Dec2009, Vol. 10 Issue 8, p947 

    Aims: Previous studies provided evidence about left ventricular systolic and diastolic dysfunction in adults with Marfan syndrome (MFS). However, in the literature, data on right ventricular and bi-atrial diastolic function are limited. We aimed to investigate whether, in the absence of...

  • Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defects. Disabella, Eliana; Grasso, Maurizia; Marziliano, Nicola; Ansaldi, Silvia; Lucchelli, Claudia; Porcu, Emanuele; Tagliani, Marilena; Pilotto, Andrea; Diegoli, Marta; Lanzarini, Luca; Malattia, Clara; Pelliccia, Antonio; Ficcadenti, Anna; Gabrielli, Orazio; Arbustini, Eloisa // European Journal of Human Genetics;Jan2006, Vol. 14 Issue 1, p34 

    TGF-β-receptor 2 (TGFBR2) gene defects have been recently associated with Marfan syndrome (MFS) with prominent cardio-skeletal phenotype in patients with negative fibrillin-1 (FBN1) gene screening. Four mutations have been identified to date in five unrelated families. We screened TGFBR2 gene...

  • Fibrillin controls TGF-B activation. Kaartinen, Vesa; Warburton, David // Nature Genetics;Mar2003, Vol. 33 Issue 3, p331 

    Secreted transforming growth factori-βs (TGF-βs) are rendered biologically inactive by binding proteins that also target and concentrate them to the extracellular matrix. Specific, but still poorly understood, activation is required for disassembly of the extracellular matrix-bound protein...


Read the Article


Sign out of this library

Other Topics